Free tool
FAERS Monitor: Prostin Vr Pediatric
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 018484 or its brand name (Prostin Vr Pediatric, Alprostadil). Reports on generic versions are filed under their own applications.
Reports
1,585
Serious
1,454
92% of reports
Hospitalization
546
Death reported
228
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- off label use126
- drug ineffective124
- haemoglobin decreased82
- lymphocyte count decreased79
- pyrexia77
- diarrhoea70
- cardiac failure64
- blood urea increased59
- condition aggravated55
- anaemia54
- blood glucose increased54
- neutrophil count increased54
- pneumonia50
- white blood cell count increased50
- incision site pain43
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 48 |
| 2005 | 64 |
| 2006 | 72 |
| 2007 | 41 |
| 2008 | 62 |
| 2009 | 31 |
| 2010 | 53 |
| 2011 | 98 |
| 2012 | 66 |
| 2013 | 35 |
| 2014 | 17 |
| 2015 | 60 |
| 2016 | 107 |
| 2017 | 155 |
| 2018 | 94 |
| 2019 | 115 |
| 2020 | 84 |
| 2021 | 86 |
| 2022 | 60 |
| 2023 | 46 |
| 2024 | 74 |
| 2025 | 57 |
| 2026 | 59 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,052,574 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| incision site painSignal | 43 | 504.1 | 373.3 | 20,320 |
| neutrophil count increasedSignal | 54 | 70.4 | 54.1 | 3,605 |
| lymphocyte count decreasedSignal | 79 | 59.6 | 48.0 | 4,475 |
| blood urea increasedSignal | 59 | 46.9 | 36.5 | 2,600 |
| white blood cell count increasedSignal | 50 | 17.3 | 13.2 | 753 |
| haemoglobin decreasedSignal | 82 | 10.6 | 8.6 | 707 |
| cardiac failureSignal | 64 | 10.6 | 8.3 | 548 |
| blood glucose increasedSignal | 54 | 3.8 | 2.9 | 110 |
| anaemiaSignal | 54 | 3.8 | 2.9 | 108 |
| pyrexiaSignal | 77 | 3.0 | 2.4 | 99 |
| condition aggravatedSignal | 55 | 2.4 | 1.9 | 44 |
| pneumoniaSignal | 50 | 2.0 | 1.6 | 26 |
| off label use | 126 | 1.9 | 1.6 | 56 |
| diarrhoea | 70 | 1.4 | 1.1 | 9 |
| drug ineffective | 124 | 1.2 | 1.1 | 6 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.